Compound Search
Compound Database
Powered by a PubChem CID-based index. Search by name, synonym, CAS number, or SMILES.
-
CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O -
2H-PYRAZINO(1,2-B)ISOQUINOLINE-2-ACETIC ACID, 1,3,4,6,11,11A-HEXAHYDRO-8,9-DIMETHOXY-3-METHYL-1,4-DIOXO-.ALPHA.-(2-PHENYLETHYL)-, ETHYL ESTER, (.ALPHA.S,3S,11AS)- CAS 103733-51-3 PubChem CID 71750760
CCOC(=O)[C@H](CCc1ccccc1)N1C(=O)[C@@H]2Cc3cc(OC)c(OC)cc3CN2C(=O)[C@@H]1C -
(5,5 inverted exclamation mark -Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6 inverted exclamation mark -dichloro-3-hydroxy-3,3 inverted exclamation mark -biindoline-2,2 inverted exclamation mark -dione) CAS 1303996-68-0 PubChem CID 72942012
O=C1Nc2cc(Cl)c(CCN3CCN(c4nsc5ccccc45)CC3)cc2C1C1(O)C(=O)Nc2cc(Cl)c(CCN3CCN(c4nsc5ccccc45)CC3)cc21 -
(1RS)-3-(Methylamino)-1-phenylpropan-1-ol; Fluoxetine Hydrochloride Imp. A (EP); Atomoxetine Hydrochloride Impurity H; Fluoxetine Hydrochloride Impurity A; Atomoxetine Impurity H; Fluoxetine Impurity A CAS 42142-52-9 PubChem CID 2733989
CNCCC(O)c1ccccc1 -
CN1CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.Cl -
N'-[(6-oxo-5-prop-2-enyl-1-cyclohexa-2,4-dienylidene)methyl]-2-[4-(phenylmethyl)-1-piperazinyl]acetohydrazide CAS 315183-21-2 PubChem CID 135421197
C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O -
Cc1c[nH]c(=O)[nH]c1=O -
1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-((S)-methylsulfinyl)phenyl)methylene)-, (1E)- CAS 38194-50-2 PubChem CID 1548885
CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C/c1ccc(S(C)=O)cc1 -
CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.Cl -
Glycopyrronium Bromide Imp. G (EP); Glycopyrrolate USP Related Compound B; Glycopyrrolate USP RC B; Glycopyrrolate Related Compound B as free base; Glycopyrrolate Related Compound B; Glycopyrronium Bromide Impurity G; Glycopyrronium Impurity G CAS 13118-11-1 PubChem CID 25727
CN1CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1 -
Chromate(1-), hydroxy(2-(hydroxy-kappaO)-5-nitro-3-(2-(2-(oxo-kappaO)-1-((phenylamino)carbonyl)propyl)diazenyl-kappaN1)benzenesulfonato(3-))-, hydrogen, compd. with 3-((2-ethylhexyl)oxy)-1-propanamine (1:1:1) CAS 94276-33-2 PubChem CID 135666555
C/C([O-])=C(/N=Nc1cc([N+](=O)[O-])cc(S(=O)(=O)[O-])c1[O-])C(=O)Nc1ccccc1.CCCCC(CC)COCCCN.[Cr+3].[H+].[OH-] -
CCOC(=O)[C@@H](CCc1ccccc1)N[C@@H]1CCc2ccccc2N(CC(=O)O)C1=O.Cl -
Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1 -
(S)-9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; DN 5455; Desmethyl Levofloxacin; UING 4-255; Levofloxacin Related Compound A (USP); Levofloxacin Related Compound A; Levofloxacin Hemihydrate Impurity B CAS 117707-40-1 PubChem CID 10958963
C[C@H]1COc2c(N3CCNCC3)c(F)cc3c(=O)c(C(=O)O)cn1c23 -
5-Heptenoic acid, 7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+-.)- CAS 54276-17-4 PubChem CID 5311100
O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O -
Rabeprazole N-Oxide; Rabeprazole Sodium Imp. D (EP); Rabeprazole Imp. D (EP); Rabeprazole USP Related Compound B; Rabeprazole USP RC B; Rabeprazole Related Compound B; Rabeprazole Sodium Impurity D; Rabeprazole Impurity D CAS 924663-38-7 PubChem CID 16095899
COCCCOc1cc[n+]([O-])c(CS(=O)c2nc3ccccc3[nH]2)c1C -
5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-AMINO-8-OXO-3-(1-PROPENYL)-, (6R-(3(Z),6.ALPHA.,7.BETA.))- CAS 106447-44-3 PubChem CID 11557762
C/C=C\C1=C(C(=O)O)N2C(=O)[C@@H](N)[C@H]2SC1 -
3-[({2-[(DIAMINOMETHYLIDENE)AMINO]-1,3-THIAZOL-4-YL}METHYL)SULFANYL]-N-SULFAMOYLPROPANAMIDE CAS 106433-44-7 PubChem CID 4626625
NC(N)=Nc1nc(CSCCC(=O)NS(N)(=O)=O)cs1 -
CCOC(=O)c1cccnc1Cl -
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-Benzimidazole; Pantoprazole Sodium Sesquihydrate Imp. D (EP); Pantoprazole Related Compound D and F Mixture; Pantoprazole Sodium Impurity D + F; Pantoprazole Impurity D + F CAS 624742-53-6 PubChem CID 21032391
COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3n2C)c1OC